Rate My Professor Prachi Mehta

Mehta is a medical researcher specializing in neuroscience and molecular biology, with a focus on amyotrophic lateral sclerosis (ALS) and TDP-43 pathology. Her expertise encompasses molecular cell biology techniques, protein biochemistry, immunofluorescence, histology, PCR, tissue culture, and grant writing. Key publications include 'Cofilin hyperphosphorylation triggers TDP-43 pathology in sporadic amyotrophic lateral sclerosis' (Brain, 2026), 'A slower-progressing TDP-43 rNLS8 mouse model for ALS: implications for preclinical and mechanistic studies' (NeuroMolecular Medicine, 2025), 'Pathological forms of TDP-43 in amyotrophic lateral sclerosis (ALS) promote aberrant telomere elongation' (Biochimica et Biophysica Acta - Molecular Basis of Disease, 2025), 'A transient protein folding response targets aggregation in the early phase of TDP-43-mediated neurodegeneration' (Nature Communications, 2024), and 'Protein disulfide isomerase endoplasmic reticulum protein 57 (ERp57) is protective against ALS-associated mutant TDP-43 in neuronal cells' (NeuroMolecular Medicine, 2024). She has produced 19 research outputs, advancing knowledge on protein misfolding, protective mechanisms, and preclinical models in ALS and related neurodegenerative conditions. Mehta has received the Nina Bushcomb Award (2019, MND Association of Victoria), Early Career Research Award (2017, Department of Biomedical Sciences, Macquarie University), University of Sydney Postgraduate Award, Northern Clinical School/Ramsay Healthcare PhD Top-Up Scholarship, Centenary Scholarship Award, The Movement Disorder Society International Travel Award, Postgraduate Student Support Scheme Award, Beryl and Jack Jacobs National Travel Award, and Kolling Student Travel Fellowship.